Phototherapy Device Market

The Phototherapy Device Market is expanding as healthcare providers increasingly adopt controlled light-based therapies for the management of dermatological conditions and neonatal jaundice. Phototherapy devices deliver specific wavelengths of light to produce therapeutic effects, offering a non-invasive treatment approach across hospitals, specialty clinics, and homecare settings. According to Maximize Market Research, the global Phototherapy Device Market was valued at approximately USD 649.37 million in 2025 and is projected to reach USD 860.30 million by 2032, growing at a CAGR of 4.1% during 2026–2032. The market is benefiting from the rising prevalence of skin disorders, increasing cases of neonatal jaundice, improvements in LED technology, and growing demand for safer and more efficient treatment systems.

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐅𝐫𝐞𝐞 𝐏𝐃𝐅 𝐁𝐫𝐨𝐜𝐡𝐮𝐫𝐞 @https://www.maximizemarketresearch.com/request-sample/121745/ 

Phototherapy Device Market Segmentation

The Phototherapy Device Market is segmented by technology type, application, end user, and region. Based on technology type, the market is categorized into conventional phototherapy, LED-based phototherapy, and fiber-optic phototherapy. Conventional phototherapy currently represents a major segment because of its established use in treating neonatal hyperbilirubinemia and certain skin disorders. Maximize Market Research estimates that the conventional phototherapy segment generated approximately USD 184.00 million in revenue in 2025 and is expected to record a CAGR of 3.94% during the forecast period. LED-based phototherapy is another important segment and is projected to grow at approximately 6.0% CAGR, supported by advantages such as energy efficiency, longer operating life, controlled wavelength delivery, and reduced heat generation.

Based on application, the market is divided into skin disease treatment and neonatal jaundice management. Skin disease treatment includes psoriasis, vitiligo, and eczema. This segment is expected to experience significant growth as phototherapy continues to be used as a non-invasive treatment option for chronic dermatological conditions. Maximize Market Research projects the skin disease treatment segment to grow at a CAGR of 5.44% during the forecast period. Neonatal jaundice management represents another critical application because phototherapy is widely used to reduce elevated bilirubin levels in newborns. The increasing need for effective neonatal care, particularly in hospitals and neonatal intensive care units, is expected to support demand for phototherapy systems.

By end user, the market is segmented into hospitals and specialty clinics and home users. Hospitals and specialty clinics accounted for a leading position, with the segment assessed at approximately USD 378.0 million in 2025. The segment benefits from the availability of specialized equipment, trained medical professionals, advanced neonatal and dermatology facilities, and greater patient access to controlled treatment protocols. Meanwhile, home-use phototherapy is emerging as an attractive opportunity as manufacturers develop compact, portable, and easier-to-operate systems that can support treatment outside conventional healthcare facilities.

Growth Drivers of the Phototherapy Device Market

One of the strongest growth drivers is the increasing prevalence of dermatological disorders. Conditions such as psoriasis, vitiligo, eczema, and other chronic skin disorders affect large patient populations worldwide and frequently require repeated or long-term management. Phototherapy provides a non-invasive treatment option that can be administered under controlled clinical conditions. The rising number of patients seeking effective alternatives to systemic treatments is therefore contributing to the adoption of phototherapy equipment. Industry research also identifies the increasing incidence of skin disorders as a central factor supporting market expansion.

The rising incidence and continuing clinical management of neonatal jaundice is another major market driver. Neonatal jaundice is common among newborns, and phototherapy is an established approach for reducing elevated bilirubin levels. Increasing investment in neonatal intensive care units, maternity hospitals, and specialized newborn-care facilities is creating sustained demand for phototherapy equipment. The neonatal segment is also encouraging manufacturers to develop systems that improve treatment effectiveness while enhancing infant comfort and reducing thermal exposure.

LED technology advancement is further transforming the market. Modern LED-based devices can offer precise wavelength delivery, lower energy consumption, longer operating lifetimes, and reduced heat output compared with some conventional systems. The transition toward digitally controlled and energy-efficient platforms is encouraging healthcare facilities to modernize their equipment. Recent market research also highlights the broader movement from traditional lamp-based systems toward LED-based and digitally controlled phototherapy platforms.

Another important factor is the increasing demand for portable and home-use phototherapy devices. Compact systems can provide greater flexibility for selected patients requiring repeated treatment while potentially reducing the need for frequent visits to healthcare facilities. The development of wearable and portable neonatal systems is similarly creating opportunities for more convenient newborn care. Home-use phototherapy is receiving growing attention, with recent industry research forecasting substantial expansion in this category through 2032.

Technological Trends and Product Innovation

Technology innovation is becoming a key competitive factor in the Phototherapy Device Market. Manufacturers are increasingly focusing on precise wavelength control, intelligent monitoring, compact designs, energy efficiency, and improved treatment consistency. Digital connectivity and smart features are also gaining importance as healthcare providers seek better monitoring and more efficient workflows. Industry research identifies smart features, connectivity, longer device lifespans, energy efficiency, and precise wavelength control as important factors shaping the phototherapy equipment landscape.

The development of wearable phototherapy systems represents another notable trend, particularly in neonatal care. Wearable and fiber-optic solutions can allow newborns to receive treatment while maintaining greater mobility and parent-child interaction compared with some conventional setups. Such products are particularly relevant to healthcare systems seeking patient-centered neonatal care. Recent industry reporting has highlighted wearable solutions designed for neonatal hyperbilirubinemia as an area of innovation.

The market is also moving toward more compact and flexible devices. Smaller systems can be easier to deploy in neonatal units, outpatient clinics, dermatology practices, and homecare environments. These innovations can expand the addressable market by making phototherapy more accessible beyond large hospitals.

Recent Developments in the Phototherapy Device Market

Recent developments demonstrate the industry's focus on LED technology, digital monitoring, wearable solutions, and strategic portfolio expansion. In May 2025, Sun Pharmaceutical Industries announced U.S. FDA approval for an LED-based device used with LEVULAN KERASTICK for treating minimally to moderately thick actinic keratosis. The BLU-U Blue Light Photodynamic Therapy Illuminator incorporates a more compact design and flexible panel shape, illustrating the broader movement toward adaptable light-based medical systems.

In March 2025, Drägerwerk expanded its neonatal-care portfolio with the BiliPredics software solution, a digital application designed to predict bilirubin levels up to 60 hours in advance. The development illustrates how phototherapy-related neonatal care is increasingly incorporating software and predictive technologies alongside physical treatment equipment.

Another notable development occurred in February 2026, when Natus Sensory acquired TheraB Medical, a developer of wearable neonatal phototherapy solutions. The acquisition expanded Natus' newborn-care capabilities and provided access to the SnugLit wearable phototherapy device for neonatal jaundice. Such strategic acquisitions demonstrate how established medical-device companies are seeking innovative portable and wearable technologies to strengthen their neonatal-care portfolios.

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐅𝐫𝐞𝐞 𝐏𝐃𝐅 𝐁𝐫𝐨𝐜𝐡𝐮𝐫𝐞 @https://www.maximizemarketresearch.com/request-sample/121745/ 

Regional Outlook

North America holds a leading position in the global Phototherapy Device Market. Maximize Market Research estimated that North America accounted for approximately 55% of the market in 2025 and is expected to register a CAGR of 4.63% during the forecast period. The region benefits from advanced healthcare infrastructure, high awareness of dermatological treatments, established neonatal care facilities, and the presence of major medical-device manufacturers.

Europe represents another significant market, supported by developed healthcare systems, strong adoption of advanced medical technologies, and increasing demand for dermatological treatment. Meanwhile, Asia Pacific offers considerable growth potential due to expanding healthcare infrastructure, rising healthcare expenditure, increasing awareness of skin disorders, and growing investment in neonatal care. Developing economies are also creating opportunities for manufacturers of cost-effective, portable, and energy-efficient devices.

Competitive Landscape

The competitive landscape includes established medical-device companies and specialized phototherapy manufacturers. Key players identified by Maximize Market Research include GE Healthcare, Atom Medical, Dräger, Herbert Waldmann, Natus Medical, Daavlin, Beurer, National Biological, Solarc Systems, UVBioTek, Nice Neotech, Signify Holding, Phoenix Medical Corporation, Strata Skin Sciences, and Medisana AG. Companies are emphasizing product innovation, LED technology, portable systems, strategic acquisitions, digital solutions, and expansion into emerging healthcare markets to strengthen their competitive positions.

For full access to the comprehensive strategic report, visit:https://www.maximizemarketresearch.com/market-report/phototherapy-device-market/121745/ 

 Future Outlook

Overall, the Phototherapy Device Market is positioned for sustained growth through 2032 as the healthcare industry increasingly values non-invasive, targeted, and technologically advanced light-based therapies. Rising skin disease prevalence, neonatal jaundice management, LED adoption, smart-device integration, and the emergence of portable and home-use systems are expected to remain key contributors to market expansion. Manufacturers that combine clinical effectiveness, energy efficiency, precise wavelength delivery, patient comfort, portability, and digital monitoring capabilities will be well positioned to capture emerging opportunities in both dermatology and neonatal care.

 About Maximize Market Research

Maximize Market Research is a multifaceted market research and consulting company with professionals from several industries. Some of the industries we cover include medical devices, pharmaceutical manufacturers, science and engineering, electronic components, industrial equipment, technology and communication, cars and automobiles, chemical products and substances, general merchandise, beverages, personal care, and automated systems. To mention a few, we provide market-verified industry estimations, technical trend analysis, crucial market research, strategic advice, competition analysis, production and demand analysis, and client impact studies.

 Contact Maximize Market Research

3rd Floor, Navale IT Park, Phase 2
Pune Bangalore Highway, Narhe,
Pune, Maharashtra 411041, India
sales@maximizemarketresearch.com
+91 96071 95908, +91 9607365656